ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

North General, MSK, Form Cancer Prevention Center.

June 30, 2000

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001